Colazal (KOL-a-zal), a new drug for ulcerative colitis
December 2000
Salix Pharmaceuticals is now marketing Colazal (KOL-a-zal), a new drug for ulcerative colitis.
Colazal (balsalazide) is broken down by bacteria in the colon to release mesalamine and an inert compound.
Asacol and Pentasa are delayed-release mesalamine products that rely on the emptying rate of the stomach and pH of the GI tract. Some is released before reaching the colon and is absorbed systemically.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote